VIKING THERAPEUTICS INC's ticker is and the CUSIP is 92686J956. A total of 3 filers reported holding VIKING THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $400 | -87.0% | 36,200 | -80.9% | 0.00% | -100.0% |
| Q2 2023 | $3,073 | +247.2% | 189,600 | +256.4% | 0.00% | +200.0% |
| Q1 2023 | $885 | +6.1% | 53,200 | -40.1% | 0.00% | 0.0% |
| Q4 2022 | $834 | -79.2% | 88,800 | +5123.5% | 0.00% | – |
| Q3 2022 | $4,000 | – | 1,700 | +750.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 200 | -98.8% | 0.00% | – |
| Q1 2022 | $51,000 | -64.8% | 17,100 | -45.9% | 0.00% | – |
| Q4 2021 | $145,000 | -43.4% | 31,600 | -22.0% | 0.00% | – |
| Q3 2021 | $256,000 | +5.8% | 40,500 | 0.0% | 0.00% | – |
| Q2 2021 | $242,000 | -33.0% | 40,500 | +6992.8% | 0.00% | -100.0% |
| Q1 2021 | $361,000 | -29.1% | 571 | -36.9% | 0.00% | 0.0% |
| Q4 2020 | $509,000 | -4.0% | 905 | -0.8% | 0.00% | 0.0% |
| Q3 2020 | $530,000 | -26.2% | 912 | -8.4% | 0.00% | 0.0% |
| Q2 2020 | $718,000 | +73.8% | 996 | +12.7% | 0.00% | 0.0% |
| Q1 2020 | $413,000 | +10.4% | 884 | +89.3% | 0.00% | 0.0% |
| Q4 2019 | $374,000 | +80.7% | 467 | +55.1% | 0.00% | 0.0% |
| Q3 2019 | $207,000 | -51.1% | 301 | -41.0% | 0.00% | 0.0% |
| Q2 2019 | $423,000 | -29.6% | 510 | -15.7% | 0.00% | -50.0% |
| Q1 2019 | $601,000 | +103.0% | 605 | +56.3% | 0.00% | +100.0% |
| Q4 2018 | $296,000 | -87.2% | 387 | -70.8% | 0.00% | -85.7% |
| Q3 2018 | $2,306,000 | +845.1% | 1,324 | +413.2% | 0.01% | +600.0% |
| Q2 2018 | $244,000 | +6000.0% | 258 | +1333.3% | 0.00% | – |
| Q1 2018 | $4,000 | – | 18 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 251,200 | $1,922,000 | 0.02% |
| SIMPLEX TRADING, LLC | 387 | $296,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |